Le Lézard
Classified in: Health, Science and technology
Subject: PDT

ORTHOFXtm FEATURES A FULL LINE OF CLEAR ALIGNER SYSTEMS USING THE NEWEST GENERATION OF PROPRIETARY POLYMERS


- New OrthoFX Website Showcases Latest Aligner Innovations -

FREMONT, Calif., March 20, 2025 /PRNewswire/ -- OrthoFXtm, a leading innovator in the clear aligner space, announces the launch of its new website showcasing a full portfolio of products with AirFlextm, previously branded as NiTimetm, as its newest polymer innovation. With the new generation of aligner offerings, OrthoFX aims to help orthodontists differentiate their practice and elevate patient satisfaction with a broad selection of aligner systems that are designed for enhanced predictability, while also giving their patients treatment options that fit their lifestyle.

"There have not been advancements in polymer technology for decades within the clear aligner category, so we are consistently challenging ourselves to push the boundaries of orthodontic innovations that support doctors and patient needs," said OrthoFX Co-founder, Ren Menon. "Although clear aligner treatments have been around for over two decades, there is ample evidence that shows predictability and patient compliance continue to be a problem for providers. We have worked closely with orthodontists to address these issues while also delivering solutions that better meet the needs of patients' habits and practices. Our new generation of clear aligners are delivering beautiful treatment outcomes and making it more effortless for patients to straighten their teeth."

OrthoFX's latest generation of aligners are showcased on its new website:

AirFlex is designed to provide enhanced comfort, compliance, and groundbreaking predictability. Featuring HyperElastictm technology, AirFlex utilizes a proprietary multi-copolymer that sets it apart from leading aligner brands that rely on off-the-shelf materials. This advancement in material engineering improves aligner performance and delivers efficient orthodontic movements because the multi-copolymer, leveraging secondary transition, conforms precisely to the outer surface of the dentition. This exact fit ensures optimal adaptation, which prevents the aligner from unseating. HyperElastic technology accommodates up to four weeks of tooth movement, conservatively reducing the risk of relapse from non-wear and minimizing the need for refinements.

"My number one priority is to provide the most efficient, predictable, and comfortable orthodontic treatment for my patients, regardless of the complexity of their cases. From my experience, patients are not wearing their aligners as required for 20 to 22 hours a day," said Dr. Neil Warshawsky, Orthodontist, Professor, and OrthoFX provider. "This is why AirFlex with 50% less wear time is a gamechanger to get the patient compliance and treatment outcomes as planned."

Discover a new generation of aligners, AirFlex, at https://www.orthofx.com/discover-airflex/.

For more information about OrthoFX and the entire product lineup, visit www.orthofx.com.

About OrthoFX:

OrthoFXtm was established by a group of pioneers in the clear aligner industry who were instrumental in advancing and scaling leading aligner brands. The founders of OrthoFX saw an opportunity to improve treatment predictability and patient compliance by reimagining next-generation polymers, software, and services. Their goal was to empower doctors to provide effective, efficient aligner systems while offering patients aligner options that fit with their daily lifestyle.

The OrthoFX portfolio of products includes FXCleartm, which features stain resistant material and smooth, scalloped edges for enhanced comfort and fit. FXBrighttm, a translucent aligner system that gives teeth a naturally whiter and straighter appearance, without the use of whitening gels, from day one of the treatment. At the forefront of OrthoFX's aligners is the AirFlextm System, designed for effortless compliance and predictability.

For more information about how to become an OrthoFX provider, visit www.orthofx.com. Connect on Facebook, Instagram, TikTok and LinkedIn. For media inquiries, please contact [email protected]

* Data on file at OrthoFX

SOURCE OrthoFX


These press releases may also interest you

at 20:30
WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized by the environmental non-profit CDP for leadership in corporate transparency and...

at 20:00
OrthoMinds, LLC ("OrthoMinds") is providing notice of a recent data security event. OrthoMinds is notifying clients and potentially impacted individuals of the event. This notice provides information about the event, OrthoMinds' response, and steps...

at 19:55
Secretome Therapeutics, a pioneering company in the field of regenerative medicine, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to STM-01, the company's neonatal cardiac progenitor cell (nCPC)...

at 19:55
Pint Pharma and PharmaEssentia announced today that ANVISA (Brazilian Health Regulatory Agency) has approved BESREMi® (ropeginterferon alfa-2b) for the treatment of adult patients with Polycythemia Vera (PV). Polycythemia Vera (PV) is a rare,...

at 19:37
Novartis today announced that oral Fabhalta® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G), to reduce proteinuria, making it the first and only treatment approved...

at 19:22
G2S2 Capital Inc. ("G2S2") announces that its wholly owned subsidiary has disposed of 50,000 common shares of Knight Therapeutics Inc. ("Knight"), representing approximately 0.05% of the outstanding common shares of Knight. G2S2's wholly owned...



News published on and distributed by: